Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Thoracic Diseases 1Lung Neoplasms 1Liver Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1986Cisplatin 1855Carboplatin 1559Gemcitabine 1454Paclitaxel 1320Bevacizumab 1318pembrolizumab 1236Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 978Magnetic Resonance Spectroscopy 969Nivolumab 936Rituximab 929Drug Therapy 914Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 815Blood Specimen Collection 815Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × HSK3486 × Clear all
NCT07028593 2026-01-28

CP-MINS

Tongji Hospital

Phase 4 Recruiting
1,058 enrolled
Thoracic

Lung Neoplasms, Thoracic Diseases

NCT06178926 2023-12-21

Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation

Zhejiang Cancer Hospital

Phase NA Unknown
80 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡